Loading patent…
AssigneeUniversity of Louisville Research Foundation, Inc.
InventorsMariusz Z. Ratajczak, Janina Ratajczak, Magdalena Kucia, Donald Miller
Estimating the term…
Methods for ex vivo expansion of very small embryonic like stem cells in the absence of feeder cells are provided. In some embodiments the methods include providing a plurality of VSELs; and growing the VSELs in a culture medium that includes a histone deacetylase inhibitor, luteinizing hormone, follicle-stimulating hormone, and optionally transforming growth factor beta in an amount that is sufficient to overcome quiescence of the VSELs. Also provided are feeder cell-free cell cultures, ex vivo expanded VSELs, pharmaceutical compositions that include the disclosed ex vivo expanded VSELs, methods for overcoming quiescence in VSELs, methods for re-establishing imprinting in VSELs, method for treating injuries to tissues in subjects, methods for repopulating cell types in subjects, methods for bone marrow transplantation, methods for treating radiation exposure in subjects, and methods that relate to regenerative medicine.
A feeder cell-free cell culture comprising a plurality of VSELs, one or more ex vivo expanded VSELs, and a culture medium, wherein the culture medium comprises a bovine serum or a serum replacement, a histone deacetylase (HDAC) inhibitor selected from the group consisting of valproic acid (VPA), nicotinic acid (NA), and nicotinamide (NAM), luteinizing hormone (LH), follicle-stimulating hormone (FSH), and optionally transforming growth factor beta (TGFβ), which together are present in an effective amount to overcome quiescence of the VSELs, resulting in expansion of the VSELs.
Dependencies are inferred from the claim text.